Taking responsibility for bioanalytical data begins with validation of the underlying assay

Our expert scientific team will ensure that your needs for bioanalytical support and regulatory guidance are perfectly met.

Our expertise in the development and validation of ultra sensitive immunoassays allows us to validate methods on ultra sensitive technology platforms in accordance with the general guidance documents. Whether you are looking for non-regulated discovery phase support, GCP clinical phase support, or IND-enabling TOX under full GLP-regime, we will make sure that immunoassay method validation is custom designed according to your expectations of bioanalytical support.